Isavuconazole Pd.C.So.In 200mg/Vial (under development)

Product description

Isavuconazole 200mg Powder for concentrate for solution for infusion
Reference Product: Cresemba® / Basilea Pharmaceutica (Pfizer)
Description: Isavuconazole is an antifungal agent which is indicated in adults for the treatment of:
• invasive aspergillosis
• mucormycosis in patients for whom amphotericin B is inappropriate
Dossier Status: On-going
Stability Studies: 2-8 oC (Long Term) & 25 oC/60% RH (accelerated)
Shelf life (Originator): Four (4) years
Batch Sizes: To be defined
Pack Sizes: To be defined / Originator pack: BT x 1 vial (10 ml)
Read more

Specifications

Categories Generic APIsGeneric Antibiotics; Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Greece

More products from ANFARM HELLAS S.A.

View all our products (37)
Isavuconazole Pd.C.So.In 200mg/Vial (under development)

Contact information

Address

Telephone

Website

View all contact information
CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Lonza

Lonza

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO ANALYTICAL DEVELOPMENT

DISSOLUTION OF OIL SOFT GELATIN CAPSULES FROM FORMULATION TO A...

Elevate your expectations. Demand more from your CDMO.

Elevate your expectations. Demand more from your CDMO.

CONTENT GROUP

CONTENT GROUP